Trending...
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
O'Donnell Brings Wealth of Antitrust, Complex Commercial Litigation Expertise in Pharma Industry
PHILADELPHIA, Jan. 24, 2023 /PRNewswire/ -- Melissa Hatch O'Donnell, a talented health care attorney with significant experience in antitrust law, False Claims Act, and other complex commercial litigation, has rejoined Troutman Pepper as a partner in the firm's Health Sciences Litigation Practice Group. O'Donnell returns to the firm's Philadelphia office after spending nearly four years in-house with Cigna, where she provided litigation and regulatory counsel, and focused on pharmacy benefit managers' relationships with pharmaceutical manufacturers, health plans, and pharmacies.
"We are delighted to welcome Melissa back to the firm," said Sean Fahey, chair of the firm's Health Sciences Litigation Practice Group. "As we see demand for top-flight health care-focused litigators continue to grow, her addition deepens our bench strength for clients, particularly in the critical areas of antitrust law and complex commercial litigation."
More on The PennZone
O'Donnell brings extensive experience handling class action and large multidistrict litigations, as well as commercial, antitrust, unfair trade practice, and health care litigation. Drawing from in-house experience at a multinational, publicly traded health solutions company, O'Donnell advises clients in the health care and life sciences sectors in matters involving civil and criminal antitrust, competition, and other regulatory risks.
"I am thrilled to return to Troutman Pepper and private practice," O'Donnell said. "My time in-house has given me critical insight into what clients value, and I look forward to applying that experience to counsel clients through their toughest antitrust, competition, and regulatory matters."
After earning her B.A. from Penn State University, O'Donnell earned both her J.D. and her M.A. in Bioethics from the University of Pennsylvania. Prior to transitioning in-house, O'Donnell began her legal career with Troutman Pepper in 2010.
Troutman Pepper's leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients with complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
More on The PennZone
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm's litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients' most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.
SOURCE Troutman Pepper Hamilton Sanders LLP
PHILADELPHIA, Jan. 24, 2023 /PRNewswire/ -- Melissa Hatch O'Donnell, a talented health care attorney with significant experience in antitrust law, False Claims Act, and other complex commercial litigation, has rejoined Troutman Pepper as a partner in the firm's Health Sciences Litigation Practice Group. O'Donnell returns to the firm's Philadelphia office after spending nearly four years in-house with Cigna, where she provided litigation and regulatory counsel, and focused on pharmacy benefit managers' relationships with pharmaceutical manufacturers, health plans, and pharmacies.
"We are delighted to welcome Melissa back to the firm," said Sean Fahey, chair of the firm's Health Sciences Litigation Practice Group. "As we see demand for top-flight health care-focused litigators continue to grow, her addition deepens our bench strength for clients, particularly in the critical areas of antitrust law and complex commercial litigation."
More on The PennZone
- $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
- Lewis County Hydrogen Alliance Launches Phase 1 Work to Turn Forest Residuals into Fuel-Grade Hydrogen and Dispatchable Clean Power
- Next Gen Fibre Selects netElastic vBNG and CGNAT to Fuel Rapid Nationwide Expansion and Eliminate Network Bottlenecks
- Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
O'Donnell brings extensive experience handling class action and large multidistrict litigations, as well as commercial, antitrust, unfair trade practice, and health care litigation. Drawing from in-house experience at a multinational, publicly traded health solutions company, O'Donnell advises clients in the health care and life sciences sectors in matters involving civil and criminal antitrust, competition, and other regulatory risks.
"I am thrilled to return to Troutman Pepper and private practice," O'Donnell said. "My time in-house has given me critical insight into what clients value, and I look forward to applying that experience to counsel clients through their toughest antitrust, competition, and regulatory matters."
After earning her B.A. from Penn State University, O'Donnell earned both her J.D. and her M.A. in Bioethics from the University of Pennsylvania. Prior to transitioning in-house, O'Donnell began her legal career with Troutman Pepper in 2010.
Troutman Pepper's leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients with complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
More on The PennZone
- Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
- Brother Marcus Unlocks the Vault
- L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
- Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm's litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients' most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.
SOURCE Troutman Pepper Hamilton Sanders LLP
Filed Under: Business
0 Comments
Latest on The PennZone
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- SKRAP Finds Hope Through Heartache on Powerful New Single "Shellshock"
- CodesClue: A Trusted AI-Based Software Development Company for Global Businesses
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Valgar LLC Launches The Briefing Room: Education Leaders
- New Novel WINCE Takes Unflinching Aim at American Gun Culture and Masculinity
- New Research Puts the Cost of Enterprise Decision Delay at $630 Billion a Year Across the Global 2000
- Easwe D10, C20, and C30: Lightweight Folding Electric Wheelchairs Built for Easier Travel
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
- Philadelphia Community Invited to Unite for Praise-A-Thon Summer Concert Benefiting Cobbs Creek
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
- New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
- The J. Wes Project Celebrates 11 Years of Love, Music & Inspiration
- Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
- MoMojo Records announces new album from Jad Tariq
- Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
- Fatal FOMO May be Your Last Roll of the Dice
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
